Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast Cancers
Inês Vaz-Luís, Prudence A. Francis, Antonio Di Meglio, et al.
American Society of Clinical Oncology Educational Book (2021), Iss. 41, pp. e47-e61
Open Access | Times Cited: 19

Showing 19 citing articles:

Localized delivery of immunotherapy via implantable scaffolds for breast cancer treatment
A. Hope, Samantha J. Wade, Morteza Aghmesheh, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 399-413
Closed Access | Times Cited: 29
Staphylococcus aureus-Derived Extracellular Vesicles Enhance the Efficacy of Endocrine Therapy in Breast Cancer Cells
Jeongshin An, Hyungju Kwon, Woosung Lim, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 2030-2030
Open Access | Times Cited: 21
A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial
Jamie M. Jacobs, Kathryn Post, Katina Massad, et al.
Cancer (2022) Vol. 128, Iss. 19, pp. 3541-3551
Open Access | Times Cited: 20
Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial
Emily A. Walsh, Kathryn Post, Katina Massad, et al.
Breast Cancer Research and Treatment (2024) Vol. 204, Iss. 3, pp. 547-559
Closed Access | Times Cited: 4
Extracellular vesicles in the treatment and diagnosis of breast cancer: a status update
Xiaoying Zhang, Caizheng Wang, Jiahui Yu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10
Exploring Contemporary Breakthroughs in Utilizing Vesicular Nanocarriers for Breast Cancer Therapy
Nalla Usha Kumari, Ekta Pardhi, Padakanti Sandeep Chary, et al.
Therapeutic Delivery (2024) Vol. 15, Iss. 4, pp. 279-303
Closed Access | Times Cited: 3
Ovarian Suppression: Early Menopause, Late Effects
Chaya Goldberg, M Greenberg, Alexandra Noveihed, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 427-438
Closed Access | Times Cited: 2
Concurrent factors associated with adherence to adjuvant endocrine therapy among women with non-metastatic breast cancer
Emily A. Walsh, Leah E. Walsh, Max Hernand, et al.
Journal of Cancer Survivorship (2024)
Closed Access | Times Cited: 2
Association Between Ki-67 Proliferative Index and Oncotype-Dx Recurrence Score in Hormone Receptor-Positive, HER2-Negative Early Breast Cancers. A Systematic Review of the Literature
Mehwish Mooghal, Muhammad Ali Akbar Khan, Mirza Rameez Samar, et al.
Breast Cancer Basic and Clinical Research (2024) Vol. 18
Open Access | Times Cited: 2
Unique sphingolipid signature identifies luminal and triple‐negative breast cancer subtypes
Animesh Kar, Nihal Medatwal, Kajal Rajput, et al.
International Journal of Cancer (2023) Vol. 152, Iss. 11, pp. 2410-2423
Closed Access | Times Cited: 6
Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy
Antonio Di Meglio, Davide Soldato, Daniele Presti, et al.
Current Opinion in Oncology (2021) Vol. 33, Iss. 6, pp. 553-573
Closed Access | Times Cited: 15
Managing Symptom Distress: Key Factors for Patients on Adjuvant Endocrine Therapy for Breast Cancer
Kathryn Post, Zeba Ahmad, Greta Jankauskaite, et al.
Journal of Pain and Symptom Management (2023)
Closed Access | Times Cited: 4
Different dosage forms of GnRHa with endocrine therapy in premenopausal hormone Receptor-Positive breast cancer
Jinna Lin, Yiye Ouyang, Yudong Li, et al.
JNCI Journal of the National Cancer Institute (2024)
Closed Access | Times Cited: 1
Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer
Luca Arecco, Roberto Borea, Isotta Martha Magaton, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 9, pp. 803-817
Closed Access | Times Cited: 1
Systemische Therapie von prämenopausalen Patientinnen mit hormonrezeptorpositivem, HER2-negativem Brustkrebs in den Frühstadien – Kontroversen und Standards in der Krankenversorgung
Volkmar Müller, Peter A. Fasching, Naiba Nabieva, et al.
Senologie - Zeitschrift für Mammadiagnostik und -therapie (2024) Vol. 21, Iss. 01, pp. 61-74
Open Access
Pharmacogenetics of Toxicities Related to Endocrine Treatment in Breast Cancer: A Systematic Review and Meta-analysis
Kinan Mokbel, Michael N. Weedon, VICTORIA MOYE, et al.
Cancer Genomics & Proteomics (2024) Vol. 21, Iss. 5, pp. 421-438
Open Access
Impact of Motivational Interviewing on Psychosocial and Symptom Outcomes During Breast Cancer Endocrine Therapy
Charlotte Ellis, Katie Reeder-Hayes, Sarah Drier, et al.
Research Square (Research Square) (2024)
Open Access
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare
Volkmar Müller, Peter A. Fasching, Naiba Nabieva, et al.
Geburtshilfe und Frauenheilkunde (2023) Vol. 83, Iss. 06, pp. 673-685
Open Access | Times Cited: 1
Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer
Young-Won Lee, Sei‐Hyun Ahn, Young-jin Lee, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0290174-e0290174
Open Access
Page 1

Scroll to top